ATE326534T1 - Methode zur behandlung von muskelkrankheiten - Google Patents

Methode zur behandlung von muskelkrankheiten

Info

Publication number
ATE326534T1
ATE326534T1 AT97906296T AT97906296T ATE326534T1 AT E326534 T1 ATE326534 T1 AT E326534T1 AT 97906296 T AT97906296 T AT 97906296T AT 97906296 T AT97906296 T AT 97906296T AT E326534 T1 ATE326534 T1 AT E326534T1
Authority
AT
Austria
Prior art keywords
muscle diseases
treating muscle
treating
diseases
igf
Prior art date
Application number
AT97906296T
Other languages
English (en)
Inventor
Geoffrey Goldspink
Shi Yu Yang
Original Assignee
Univ London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ London filed Critical Univ London
Application granted granted Critical
Publication of ATE326534T1 publication Critical patent/ATE326534T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT97906296T 1996-03-11 1997-03-11 Methode zur behandlung von muskelkrankheiten ATE326534T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9605124.8A GB9605124D0 (en) 1996-03-11 1996-03-11 Method of treating muscular disorders

Publications (1)

Publication Number Publication Date
ATE326534T1 true ATE326534T1 (de) 2006-06-15

Family

ID=10790201

Family Applications (2)

Application Number Title Priority Date Filing Date
AT97906296T ATE326534T1 (de) 1996-03-11 1997-03-11 Methode zur behandlung von muskelkrankheiten
AT06003275T ATE454451T1 (de) 1996-03-11 1997-03-11 Methode zur behandlung von muskelkrankheiten

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT06003275T ATE454451T1 (de) 1996-03-11 1997-03-11 Methode zur behandlung von muskelkrankheiten

Country Status (10)

Country Link
US (1) US6221842B1 (de)
EP (2) EP1726651B1 (de)
JP (1) JP2000506729A (de)
AT (2) ATE326534T1 (de)
DE (2) DE69739737D1 (de)
DK (2) DK0894136T3 (de)
ES (2) ES2265649T3 (de)
GB (1) GB9605124D0 (de)
PT (2) PT1726651E (de)
WO (1) WO1997033997A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1148404A (zh) * 1994-05-16 1997-04-23 国际壳牌研究有限公司 提高烃类渣油质量的方法
US7118752B2 (en) * 1998-07-22 2006-10-10 University Of Connecticut Compositions and methods for inhibiting the proliferation and invasiveness of malignant cells comprising E-domain peptides of IGF-I
US7700353B2 (en) * 1998-07-22 2010-04-20 E-P Therapeutics, Inc. Compositions and methods for inducing apoptosis in tumor cells
GB9926968D0 (en) * 1999-11-15 2000-01-12 Univ London Treatment of neurological disorders
GB0011278D0 (en) * 2000-05-10 2000-06-28 Univ London Repair of nerve damage
US7326417B2 (en) 2001-09-11 2008-02-05 Merial Ltd. IGF-1 as feline vaccine adjuvant, in particular against feline retroviruses
FR2829498B1 (fr) * 2001-09-11 2003-11-28 Merial Sas Igf-1 comme adjuvant de vaccin felin, notamment contre les retrovirus felins
GB0202906D0 (en) * 2002-02-07 2002-03-27 Univ London Prevention of myocardial damage
US20050125914A1 (en) * 2003-11-18 2005-06-16 Gerard Malle Hair shaping composition comprising at least one- non-hydroxide base
WO2006097682A1 (en) * 2005-03-18 2006-09-21 Ucl Business Plc Mechano growth factor peptides and their use
US20090221072A1 (en) * 2006-02-15 2009-09-03 Chen Thomas T Compositions and methods for modulating cell differentiation
CN101466398A (zh) * 2006-06-09 2009-06-24 诺瓦提斯公司 稳定的胰岛素样生长因子多肽
KR101459789B1 (ko) 2006-06-09 2014-11-07 노파르티스 아게 안정화된 인슐린-유사 성장 인자 폴리펩티드

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963665A (en) * 1986-01-07 1990-10-16 Washington University Human preproinsulin-like growth factor I
SE9100099D0 (sv) 1991-01-11 1991-01-11 Kabi Pharmacia Ab Use of growth factor
US5298422A (en) 1991-11-06 1994-03-29 Baylor College Of Medicine Myogenic vector systems
US5252479A (en) 1991-11-08 1993-10-12 Research Corporation Technologies, Inc. Safe vector for gene therapy
AU1178395A (en) * 1993-11-12 1995-05-29 North Shore University Hospital Research Corporation Method of treating muscular dystrophy

Also Published As

Publication number Publication date
ES2337917T3 (es) 2010-04-30
DK0894136T3 (da) 2006-09-18
DK1726651T3 (da) 2010-04-12
DE69739737D1 (de) 2010-02-25
EP1726651A1 (de) 2006-11-29
GB9605124D0 (en) 1996-05-08
US6221842B1 (en) 2001-04-24
WO1997033997A1 (en) 1997-09-18
DE69735883T2 (de) 2007-04-19
ES2265649T3 (es) 2007-02-16
EP1726651B1 (de) 2010-01-06
PT1726651E (pt) 2010-04-08
ATE454451T1 (de) 2010-01-15
EP0894136B1 (de) 2006-05-17
PT894136E (pt) 2006-10-31
EP0894136A1 (de) 1999-02-03
JP2000506729A (ja) 2000-06-06
DE69735883D1 (de) 2006-06-22

Similar Documents

Publication Publication Date Title
DE69739792D1 (de) Verfahren zur Behandlung von Augenerkrankungen
ATE326534T1 (de) Methode zur behandlung von muskelkrankheiten
DE69838338D1 (de) Verwendung von antimykotica zur topischen behandlung von pilz-induzierten schleimhautentzündungen
DE59607691D1 (de) Anordnung zur elektro-thermischen behandlung des menschlichen oder tierischen körpers
ATE247504T1 (de) Vorrichtung zur behandlung des menschlichen körpers durch endermatische elektrotherapie
DE3786893D1 (de) Piperidinderivat zur schmerzbehandlung.
DE69729004D1 (de) Photodynamische therapie zur behandlung von osteosrthritis
DE69129267D1 (de) Methode zur behandlung intestinaler krankheiten
DE69918145D1 (de) Verwendung von diltiazem zur behandlung von pathologien der netzhaut
DE69729735D1 (de) Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen
ATE335759T1 (de) Verfahren und zusammensetzungen für die diagnose und die behandlung von krankheiten, die mit eisenüberschuss oder eisenmangel assoziiert sind.
EP0967276A3 (de) Antitumor-Mittel dass Salmosin enthält
ATE251462T1 (de) Verfahren zur behandlung von narbengewebe
EA199901061A1 (ru) Новые соли врс-пептидов с органопротективной активностью, способ их получения и их использование в терапии
DE69108116D1 (de) Vorrichtung zur Stimulation lebenden Gewebes.
EP1143996A4 (de) Methode zur behandlung von chronischen herzerkrankungen
DE3865283D1 (de) Butylhydroxyanisole zur behandlung von retrovirus-krankheiten.
ATE295731T1 (de) Olanzapine zur behandlung von drogenmissbrauch
ATE319472T1 (de) Verfahren zur behandlung der gefässerkrankungen mit aktiviertem protein c
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
DE59410340D1 (de) Verwendung von Bradykinin-Antagonisten zur Behandlung von Viruserkrankungen
DE69813354D1 (de) Mittel zur Behandlung von Herzkrankheiten
DE69430807D1 (de) Verfahren zur behandlung von lebererkrankungen und ähnlichen indikationen mit vasodilatierenden wirkstoffen
ATE299021T1 (de) Verwendung von oxazolidinonderivaten zur behandlung von psoriasis
DE3772047D1 (de) Pyrazin zur behandlung von haemodynamischen und metabolischen krankheiten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0894136

Country of ref document: EP